Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biopha.2021.111599 http://scihub22266oqcxt.onion/10.1016/j.biopha.2021.111599 33915502!8062574!33915502     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biomed+Pharmacother 2021 ; 139 (ä): 111599 Nephropedia Template TP {{tp|p=33915502|t=2021. Novel and emerging mutations of SARS-CoV-2: Biomedical implications |pdf=|usr=}}{{33915502}} gab.com Text Novel and emerging mutations of SARS-CoV-2: Biomedical implications JO: Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=33915502 #FOAvip Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its virulence and pathogenesis. Hence, understanding these features can be used to predict the future transmission dynamics of SARS-CoV-2 infection, drug development, and vaccine. In this review, we discuss the most recent findings on the mutations in the SARS-CoV-2, which provide valuable information on the genetic diversity of SARS-CoV-2, especially for DNA-based diagnosis, antivirals, and vaccine development for COVID-19. Twit Text FOAVip Novel and emerging mutations of SARS-CoV-2: Biomedical implications ????Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=33915502 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33915502 #FOAvip English Wikipedia <ref>{{Cite pmid|33915502}}</ref> Novel and emerging mutations of SARS-CoV-2: Biomedical implications #MMPMID33915502 Mohammadi E; Shafiee F; Shahzamani K; Ranjbar MM; Alibakhshi A; Ahangarzadeh S; Beikmohammadi L; Shariati L; Hooshmandi S; Ataei B; Javanmard SH Biomed Pharmacother 2021[Jul]; 139 (ä): 111599 PMID33915502show ga Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its virulence and pathogenesis. Hence, understanding these features can be used to predict the future transmission dynamics of SARS-CoV-2 infection, drug development, and vaccine. In this review, we discuss the most recent findings on the mutations in the SARS-CoV-2, which provide valuable information on the genetic diversity of SARS-CoV-2, especially for DNA-based diagnosis, antivirals, and vaccine development for COVID-19. |*Mutation[MESH] |COVID-19/*genetics[MESH] |Genome, Viral[MESH] |Humans[MESH] |SARS-CoV-2/*genetics[MESH]Novel and emerging mutations of SARS-CoV-2: Biomedical implications (epmc).pdf DeepDyve Pubget Overpricing